Literature DB >> 17618960

Reduced capacity for fatty acid oxidation in rats with inherited susceptibility to diet-induced obesity.

Hong Ji1, Mark I Friedman.   

Abstract

High-fat, energy-dense diets promote weight gain and obesity in humans and other animals, but the mechanisms underlying such diet-induced obesity remain elusive. To determine whether a reduced capacity to oxidize fat is involved in the etiology of diet-induced obesity, we examined different measures of fatty acid oxidation in rats selectively bred for susceptibility (DIO) or resistance (DR) to dietary obesity before and after they were fed a high-fat diet and became obese. DIO rats eating a low-fat diet oxidized less dietary fatty acid in vivo and had lower levels of plasma ketone bodies during fasting compared with DR rats. Lean DIO rats fed a low-fat diet showed reduced liver messenger RNA expression of CD36, which transports fatty acids across cell membranes, and long-chain acyl-coenzyme A dehydrogenase (ACADL), which catalyzes the first step in the mitochondrial beta-oxidation of fatty acids. The deficit in CD36 and ACADL messenger RNA expression was also seen in obese DIO rats that had been eating a high-fat diet and, in addition, was accompanied by reduced expression of liver carnitine palmitoyl transferase I, the enzyme that mediates transport of long-chain fatty acids into mitochondria. No differences were found in the expression of liver enzymes involved in fat synthesis; however, in muscle, DIO rats fed the low-fat, but not high-fat, diet showed greater expression of diacylglycerol O-acyltransferase 1 and lipoprotein lipase than did DR rats. Expression of muscle enzymes involved in fatty acid oxidation was similar in the 2 groups. These findings provide a metabolic mechanism for the development of diet-induced obesity and thus suggest potential targets for intervention strategies to treat or prevent it.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17618960      PMCID: PMC1995409          DOI: 10.1016/j.metabol.2007.04.006

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  37 in total

Review 1.  Metabolic predictors of weight gain.

Authors:  E Ravussin; J F Gautier
Journal:  Int J Obes Relat Metab Disord       Date:  1999-02

Review 2.  The role of dietary fat in obesity.

Authors:  A Golay; E Bobbioni
Journal:  Int J Obes Relat Metab Disord       Date:  1997-06

Review 3.  Fat metabolism in the predisposition to obesity.

Authors:  A Astrup; A Raben; B Buemann; S Toubro
Journal:  Ann N Y Acad Sci       Date:  1997-09-20       Impact factor: 5.691

4.  Phenotype-based treatment of dietary obesity: differential effects of fenofibrate in obesity-prone and obesity-resistant rats.

Authors:  Hong Ji; Lisa V Outterbridge; Mark I Friedman
Journal:  Metabolism       Date:  2005-04       Impact factor: 8.694

5.  CD36 deficiency impairs intestinal lipid secretion and clearance of chylomicrons from the blood.

Authors:  Victor A Drover; Mohammad Ajmal; Fatiha Nassir; Nicholas O Davidson; Andromeda M Nauli; Daisy Sahoo; Patrick Tso; Nada A Abumrad
Journal:  J Clin Invest       Date:  2005-04-07       Impact factor: 14.808

6.  Homozygous carnitine palmitoyltransferase 1a (liver isoform) deficiency is lethal in the mouse.

Authors:  Lara R Nyman; Keith B Cox; Charles L Hoppel; Janos Kerner; Barry L Barnoski; Doug A Hamm; Liqun Tian; Trenton R Schoeb; Philip A Wood
Journal:  Mol Genet Metab       Date:  2005 Sep-Oct       Impact factor: 4.797

7.  Metabolic responses to intracerebroventricular leptin and restricted feeding.

Authors:  T Wang; D L Hartzell; B S Rose; W P Flatt; M G Hulsey; N K Menon; R A Makula; C A Baile
Journal:  Physiol Behav       Date:  1999 Jan 1-15

8.  CD36 deficiency in mice impairs lipoprotein lipase-mediated triglyceride clearance.

Authors:  Jeltje R Goudriaan; Marion A M den Boer; Patrick C N Rensen; Maria Febbraio; Folkert Kuipers; Johannes A Romijn; Louis M Havekes; Peter J Voshol
Journal:  J Lipid Res       Date:  2005-07-16       Impact factor: 5.922

Review 9.  Fatty acid oxidation and control of food intake.

Authors:  Monika Leonhardt; Wolfgang Langhans
Journal:  Physiol Behav       Date:  2004-12-30

10.  Arcuate NPY neurons and energy homeostasis in diet-induced obese and resistant rats.

Authors:  B E Levin
Journal:  Am J Physiol       Date:  1999-02
View more
  17 in total

1.  Reduced accumbens dopamine in Sprague-Dawley rats prone to overeating a fat-rich diet.

Authors:  Pedro Rada; Miriam E Bocarsly; Jessica R Barson; Bartley G Hoebel; Sarah F Leibowitz
Journal:  Physiol Behav       Date:  2010-07-16

2.  Intrinsic (Genetic) Aerobic Fitness Impacts Susceptibility for Metabolic Disease.

Authors:  John P Thyfault; E Matthew Morris
Journal:  Exerc Sport Sci Rev       Date:  2017-01       Impact factor: 6.230

Review 3.  Trafficking of dietary fat and resistance to obesity.

Authors:  Daniel H Bessesen; Sarah Bull; Marc A Cornier
Journal:  Physiol Behav       Date:  2008-04-22

4.  SIRT3 deficiency and mitochondrial protein hyperacetylation accelerate the development of the metabolic syndrome.

Authors:  Matthew D Hirschey; Tadahiro Shimazu; Enxuan Jing; Carrie A Grueter; Amy M Collins; Bradley Aouizerat; Alena Stančáková; Eric Goetzman; Maggie M Lam; Bjoern Schwer; Robert D Stevens; Michael J Muehlbauer; Sanjay Kakar; Nathan M Bass; Johanna Kuusisto; Markku Laakso; Frederick W Alt; Christopher B Newgard; Robert V Farese; C Ronald Kahn; Eric Verdin
Journal:  Mol Cell       Date:  2011-10-21       Impact factor: 17.970

Review 5.  Mitochondrial protein acylation and intermediary metabolism: regulation by sirtuins and implications for metabolic disease.

Authors:  John C Newman; Wenjuan He; Eric Verdin
Journal:  J Biol Chem       Date:  2012-10-18       Impact factor: 5.157

6.  A decrease in DKK1, a WNT inhibitor, contributes to placental lipid accumulation in an obesity-prone rat model.

Authors:  Rita S Strakovsky; Yuan-Xiang Pan
Journal:  Biol Reprod       Date:  2012-03-22       Impact factor: 4.285

Review 7.  SIRT3 regulates progression and development of diseases of aging.

Authors:  Eoin McDonnell; Brett S Peterson; Howard M Bomze; Matthew D Hirschey
Journal:  Trends Endocrinol Metab       Date:  2015-06-29       Impact factor: 12.015

8.  Hepatic CB1 receptor is required for development of diet-induced steatosis, dyslipidemia, and insulin and leptin resistance in mice.

Authors:  Douglas Osei-Hyiaman; Jie Liu; Liang Zhou; Grzegorz Godlewski; Judith Harvey-White; Won-il Jeong; Sándor Bátkai; Giovanni Marsicano; Beat Lutz; Christoph Buettner; George Kunos
Journal:  J Clin Invest       Date:  2008-09       Impact factor: 14.808

9.  A metabolic prosurvival role for PML in breast cancer.

Authors:  Arkaitz Carracedo; Dror Weiss; Amy K Leliaert; Manoj Bhasin; Vincent C J de Boer; Gaelle Laurent; Andrew C Adams; Maria Sundvall; Su Jung Song; Keisuke Ito; Lydia S Finley; Ainara Egia; Towia Libermann; Zachary Gerhart-Hines; Pere Puigserver; Marcia C Haigis; Elefteria Maratos-Flier; Andrea L Richardson; Zachary T Schafer; Pier P Pandolfi
Journal:  J Clin Invest       Date:  2012-08-13       Impact factor: 14.808

10.  Mice lacking angiotensin-converting enzyme have increased energy expenditure, with reduced fat mass and improved glucose clearance.

Authors:  Anura P Jayasooriya; Michael L Mathai; Lesley L Walker; Denovan P Begg; Derek A Denton; David Cameron-Smith; Gary F Egan; Michael J McKinley; Paula D Rodger; Andrew J Sinclair; John D Wark; Harrison S Weisinger; Mark Jois; Richard S Weisinger
Journal:  Proc Natl Acad Sci U S A       Date:  2008-04-28       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.